Heroin use falling across Scotland, University of Glasgow study

A new report by the Centre for Drug Misuse Research at the University of Glasgow reveals that the number of people
misusing heroin in Scotland has dropped. The research shows a near 8% drop in the number of problem drug users since 2000.



The report entitled 'Estimating the National and Local Prevalence of Problem Drug Use in Scotland, 2003' found that the
estimated number of people misusing opiates and/or benzodiazepines had fallen from 55,800 in 2000 - the first year for which
a reliable estimate was established - to 51,582 in 2003, a fall of 7.6%.


The research, which focuses on 15-54 year olds, shows a fall in the estimated number of Scots who are taking particularly
damaging drugs like heroin and valium.


It also highlights a decrease nationally in the numbers of addicts who are injecting, but around 18,737 still inject. The
highest drug injecting prevalence is in the Argyll & Clyde, Greater Glasgow and Grampian NHS Board areas, where around 1% of
the population inject drugs.


Drug related deaths were down in 2003 but over one percent of Scots are still misusing heroin and valium, or other opiates
and/or benzodiazepines.


The number of users of crack cocaine is still relatively high in the city of Aberdeen, with over 1,000 users.


Dr Gordon Hay, Senior Research Fellow at the University of Glasgow, and one of the authors of the report, said a growing
number of people are giving up heroin.


He said: 'A drug like heroin takes years to overcome an addiction for, but hopefully these figures show people are beginning
to stop and embrace training and employment. However, the fact that around 1% of Scots are still misusing substances such as
heroin is a very real concern.'


Around 30% of drug users are female and 70% are male in Scotland.


The research was carried out for the Scottish Executive by the Centre for Drug Misuse Research at the University of Glasgow
and the Scottish Centre for Infection and Environmental Health.


For more information contact: Jenny Murray, Press Officer, University of Glasgow, Tel: 0141 330 8593, Email:
Jennifer.murrayadmin.gla.ac or Dr Gordon Hay,Centre for Drug Misuse Research, University of Glasgow, Tel: 0141 330 5413



NOTES FOR EDITORS


'Valium' is a trademark for the drug diazepam, one of the family of drugs called benzodiazepines. They are prescribed for
conditions such as insomnia (difficulty sleeping) and anxiety. Products are no longer marketed under the trademark 'Valium'.
A wide range of other benzodiazepine drugs are prescribable.


Jenny Murray

jennifer.murrayadmin.gla.ac

University of Glasgow